Matrixx Initiatives (MTXX) Bouncing On Reported Positive News-Reuters

July 2, 2009 1:49 PM EDT

Matrixx Initiatives (Nasdaq: MTXX) complaint data show "some degree" of loss of smell resulted in complaints by about 3.5 persons for every 100,000 units, according to according to Reuters from a FDA report.

Matrixx data shows peak rate for loss of smell was in 2004 with complaints reaching about 6.7 for every 100,000 units sold.

According to Reuters, the FDA inspector says Matrixx official said coordination of various procedures has improved over time.

Matrixx has bounced 29% to $7.08 on this story from Reuters.

Create E-mail AlertRelated Categories

Corporate News
FDA
Hot List
Trader Talk

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?